Items per page
Sort by

Send to:

Choose Destination

Results: 8

Cited In for PubMed (Select 7724101)


Vulval cancer and HPV vaccination in recurrent disease.

Gustafson LW, Gade M, Blaakær J.

Clin Case Rep. 2014 Dec;2(6):243-6. doi: 10.1002/ccr3.93. Epub 2014 Nov 17.


Human papillomavirus prevalence in invasive laryngeal cancer in the United States.

Hernandez BY, Goodman MT, Lynch CF, Cozen W, Unger ER, Steinau M, Thompson T, Saber MS, Altekruse SF, Lyu C, Saraiya M; HPV Typing of Cancer Workgroup.

PLoS One. 2014 Dec 29;9(12):e115931. doi: 10.1371/journal.pone.0115931. eCollection 2014.


Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes.

Sandberg A, Lindell G, Källström BN, Branca RM, Danielsson KG, Dahlberg M, Larson B, Forshed J, Lehtiö J.

Mol Cell Proteomics. 2012 Jul;11(7):M112.016998. doi: 10.1074/mcp.M112.016998. Epub 2012 Apr 12.


Human papillomavirus genotyping and e6/e7 mRNA expression in greek women with intraepithelial neoplasia and squamous cell carcinoma of the vagina and vulva.

Tsimplaki E, Argyri E, Michala L, Kouvousi M, Apostolaki A, Magiakos G, Papassideri I, Panotopoulou E.

J Oncol. 2012;2012:893275. doi: 10.1155/2012/893275. Epub 2011 Dec 5.


Human papillomavirus-related gynecologic neoplasms: screening and prevention.

Growdon WB, Del Carmen M.

Rev Obstet Gynecol. 2008 Fall;1(4):154-61.


A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States.

Insinga RP, Liaw KL, Johnson LG, Madeleine MM.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1611-22. doi: 10.1158/1055-9965.EPI-07-2922. Review.


Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma.

Rosenthal AN, Hopster D, Ryan A, Jacobs IJ.

Br J Cancer. 2003 Jan 27;88(2):251-6.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk